Abstract
Pulmonary hypertension (PH) is associated with decreased overall survival in patients with chronic lung disease. The purpose of this study was to determine the effect of echocardiographic evidence of PH on 1-year survival in patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease (COPD). This is a retrospective study of patients admitted to a respiratory intermediate care unit with COPD exacerbation between October 1, 2002 and September 30, 2004. All patients who had 2D echocardiograms and pulmonary function tests done within 12 months prior to hospital admission or during the admission were examined. Charts were reviewed for the following outcomes: length of hospital stay, need for mechanical ventilation, survival at discharge, and mortality over the next year. Data were analyzed using multiple logistic regression and p values calculated using Fisher’s exact test. Forty-three patients met study entry criteria, and PH, defined as systolic right ventricular pressure greater than 45 mmHg, was found in 23 (53%). Sixteen of the 23 patients (70%) with PH died during the 1-year follow-up period compared to 5 of 20 (25%) patients with no PH (p = 0.0058). The effect of PH on survival was independent of age, forced expiratory volume in 1 s (FEV1), arterial pH, pCO2, or pO2 (p < 0.01). Echocardiographic evidence of PH is associated with increased 1-year mortality in patients admitted with COPD exacerbation. Further studies are needed to determine if PH is a cause of increased mortality in this population or an indicator of other cardiovascular disease.
Similar content being viewed by others
Abbreviations
- BMI:
-
Body mass index
- COPD:
-
Chronic obstructive pulmonary disease
- FEV1 :
-
Forced expiratory volume in one second
- GOLD:
-
Global Initiative for Chronic Obstructive Lung Disease
- ICD9:
-
International Classification of Diseases
- mmHg:
-
Millimeters of mercury
- PAP:
-
Pulmonary arterial pressure
- mPAP:
-
Mean pulmonary arterial pressure
- PAH:
-
Pulmonary arterial hypertension
- pCO2 :
-
Partial pressure of carbon dioxide
- PFT:
-
Pulmonary function test
- PH:
-
Pulmonary hypertension
- pO2 :
-
Partial pressure of oxygen
- RAP:
-
Right atrial pressure
- RV:
-
Right ventricle
- RVSP:
-
Right ventricular systolic pressure
- sPAP:
-
Systolic pulmonary artery pressure
- TR:
-
Tricuspid regurgitation
- TRV:
-
Tricuspid regurgitant velocity
References
Mannino DM, Gagnon RC, Petty TL et al (2000) Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med 160:1683–1689
Mannino DM, Homa DM, Akinbami LJ et al (2002) Surveillance for asthma–United States, 1980–1999. MMWR Surveill Summ 51:1–13
Ourednik A, Suza Z (1975) How long does the pulmonary hypertension last in chronic obstructive pulmonary disease? In: Widimsky J (ed) Progress in respiratory research: pulmonary hypertension. Karger, Basel, pp 4–28
Weitzenblum E, Hirth C, Ducolone A et al (1981) Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. Thorax 36:752–758
Cooper R, Ghali J, Simmons BE et al (1991) Elevated pulmonary artery pressure. An independent predictor of mortality. Chest 99:112–120
Kessler R, Faller M, Fourgaut G et al (1999) Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 159:158–164
Oswald-Mammosser M, Weitzenblum E, Quoix E et al (1995) Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure. Chest 107:1193–1198
Smith KJ, Pesce RR (1994) Pulmonary artery catheterization in exacerbations of COPD requiring mechanical ventilation: a cost-effectiveness analysis. Respir Care 39(10):961–967
Higham MA, Dawson D, Joshi J et al (2001) Utility of echocardiography in assessment of pulmonary hypertension secondary to COPD. Eur Respir J 17(3):350–355
Chaouat A, Bugnet AS, Kadaoui N et al (2005) Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 172(2):189–194
Weitzenblum E, Chaouat A (2005) Severe pulmonary hypertension in COPD: is it a distinct disease? Chest 127(5):1480–1482
Wuertemberger G, Zielinsky J, Sliwinsky P (1990) Survival in chronic obstructive pulmonary disease after diagnosis of pulmonary hypertension related to long-term oxygen therapy. Lung Suppl 168:762–769
Arcasoy SM, Christie JD, Ferrari VA et al (2003) Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 167:735–740
Bredikis AJ, Liebson PR (1998) The echocardiogram in COPD: estimating right heart pressures. J Respir Dis 19:191–198
Fabbri LM, Hurd SS (2003) GOLD scientific committee. Global strategy for the diagnosis, management and prevention of COPD: 2003 update. Eur Respir J 22(1):1–2
Simonson JS, Schiller NB (1988) Sonospirometry: a new method for noninvasive estimation of mean right atrial pressure based on two-dimensional echographic measurements of the inferior vena cava during measured inspiration. J Am Coll Cardiol 11:557–564
Groenewegen KH, Schols AM, Wouters EF (2003) Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 124(2):459–467
Sukumalchantra Y, Dinakara P, Williams MH (1966) Prognosis of patients with chronic obstructive pulmonary disease after hospitalization for acute ventilatory failure: a three year follow-up study. Am Rev Respir Dis 93:215–222
Blanco I, Gimeno E, Munoz PA et al (2010) Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Am J Respir Crit Care Med 181:270–278
Stolz D, Rasch H, Linka A et al (2008) A randomised, controlled trial of bosentan in severe COPD. Eur Respir J 32:619–628
Thabut G, Dauriat G, Stern JB et al (2005) Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest 127:1531–1536
Scharf SM, Iqbal M, Keller C, National Emphysema Treatment Trial (NETT) Group et al (2002) Hemodynamic characterization of patients with severe emphysema. Am J Respir Crit Care Med 166:314–322
Joppa P, Petrasova D, Stancak B et al (2006) Systemic inflammation in patients with COPD and pulmonary hypertension. Chest 130:326–333
Fisher MR, Forfia PR, Chamera E et al (2009) Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med 179:615–621
Acknowledgment
This study was supported by AHA Established Investigator Grant HN 240914 (JRK).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stone, A.C., Machan, J.T., Mazer, J. et al. Echocardiographic Evidence of Pulmonary Hypertension is Associated with Increased 1-year Mortality in Patients Admitted with Chronic Obstructive Pulmonary Disease. Lung 189, 207–212 (2011). https://doi.org/10.1007/s00408-011-9293-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00408-011-9293-4